TREK-1 currents in smooth muscle cells from pregnant human myometrium. 2013

Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
Department of Pharmacology, Center for Molecular Medicine, University of Nevada School of Medicine, Reno, Nevada.

The mechanisms governing maintenance of quiescence during pregnancy remain largely unknown. The current study characterizes a stretch-activated, tetraethylammonium-insensitive K(+) current in smooth muscle cells isolated from pregnant human myometrium. This study hypothesizes that these K(+) currents can be attributed to TREK-1 and that upregulation of this channel during pregnancy assists with the maintenance of a negative cell membrane potential, conceivably contributing to uterine quiescence until full term. The results of this study demonstrate that, in pregnant human myometrial cells, outward currents at 80 mV increased from 4.8 ± 1.5 to 19.4 ± 7.5 pA/pF and from 3.0 ± 0.8 to 11.8 ± 2.7 pA/pF with application of arachidonic acid (AA) and NaHCO3, respectively, causing intracellular acidification. Similarly, outward currents were inhibited following application of 10 μM fluphenazine by 51.2 ± 9.8% after activation by AA and by 73.9 ± 4.2% after activation by NaHCO3. In human embryonic kidney (HEK-293) cells stably expressing TREK-1, outward currents at 80 mV increased from 91.0 ± 23.8 to 247.5 ± 73.3 pA/pF and from 34.8 ± 8.9 to 218.6 ± 45.0 pA/pF with application of AA and NaHCO3, respectively. Correspondingly, outward currents were inhibited 89.5 ± 2.3% by 10 μM fluphenazine following activation by AA and by 91.6 ± 3.4% following activation by NaHCO3. Moreover, currents in human myometrial cells were activated by stretch and were reduced by transfection with small interfering RNA or extracellular acidification. Understanding gestational regulation of expression and gating of TREK-1 channels could be important in determining appropriate maintenance of uterine quiescence during pregnancy.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009215 Myometrium The smooth muscle coat of the uterus, which forms the main mass of the organ. Uterine Muscle,Muscle, Uterine,Muscles, Uterine,Uterine Muscles
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
March 1998, American journal of obstetrics and gynecology,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
June 2016, Fukushima journal of medical science,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
December 1999, Pflugers Archiv : European journal of physiology,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
August 1989, The American journal of physiology,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
July 1999, European journal of pharmacology,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
May 2004, The Prostate,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
January 1986, Biofizika,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
September 1995, The American journal of physiology,
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
April 1989, Journal of applied physiology (Bethesda, Md. : 1985),
Nathanael S Heyman, and Chad L Cowles, and Scott D Barnett, and Yi-Ying Wu, and Charles Cullison, and Cherie A Singer, and Normand Leblanc, and Iain L O Buxton
September 1991, British journal of pharmacology,
Copied contents to your clipboard!